Annual report pursuant to Section 13 and 15(d)

Business and Summary of Significant Accounting Policies (Details Narrative)

v3.22.1
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net loss $ 1,420,000 $ 2,415,000  
Cash used in operations 722,000 969,000  
Stockholders deficit 4,173,000 3,507,000 $ 2,269,000
Debt in default 1,333,000    
Cash 114,000 52,000  
Asset impairment 0 0  
Research and development costs $ 350,000 $ 355,000  
Stock Options [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 31,080,601 32,480,601  
Warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 19,977,149 8,683,677  
Convertible Notes [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 24,100,887 13,184,099  
Patent Costs [Member]      
Operating expenses $ 20,000 $ 15,000